66 assets in Adult Acute Lymphoblastic Leukemia

Therapeutic assets addressing Adult Acute Lymphoblastic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Mercaptopurine Anhydrous Adult Acute Lymphoblastic Leukemia	Shanxi Bethune Hospital	P4	A (81)
Cyclophosphamide Adult Acute Lymphoblastic Leukemia	The First Affiliated Hospital of Zhengzhou University	P4	BBB (79)
Cytarabine Adult Acute Lymphoblastic Leukemia	PETHEMA Foundation	P4	BBB (79)
Dexasone Adult Acute Lymphoblastic Leukemia	Shanxi Bethune Hospital	P4	BBB (79)
Asparaginase Adult Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P4	BBB (78)
Vindesine Adult Acute Lymphoblastic Leukemia	Shanxi Bethune Hospital	P4	BBB (78)
Adriamycin Adult Acute Lymphoblastic Leukemia	University of Washington	P4	BBB (77)
Methotrexate Adult Acute Lymphoblastic Leukemia	PETHEMA Foundation	P4	BBB (77)
(+)-Vincristine Adult Acute Lymphoblastic Leukemia	PETHEMA Foundation	P4	BBB (77)
Idarubicin Adult Acute Lymphoblastic Leukemia	Shanxi Bethune Hospital	P4	BBB (76)
Etoposide Adult Acute Lymphoblastic Leukemia	Shanxi Bethune Hospital	P4	BBB (75)
Fludarabine Adult Acute Lymphoblastic Leukemia	Northside Hospital, Inc.	P4	BBB (75)
Daunomycin Adult Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P4	BBB (74)
Rituximab Adult Acute Lymphoblastic Leukemia	University of Washington	P4	BBB (72)
Busulfanum Adult Acute Lymphoblastic Leukemia	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran	P2/3	BB (70)
Tacrolimus Adult Acute Lymphoblastic Leukemia	Sumithira Vasu	P2	BB (69)
Cladribine Adult Acute Lymphoblastic Leukemia	Fifth Affiliated Hospital, Sun Yat-Sen University	P4	BB (68)
Prednisone Adult Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P3	BB (68)
Thiotepa Adult Acute Lymphoblastic Leukemia	Fifth Affiliated Hospital, Sun Yat-Sen University	P2/3	BB (68)
Vincristine Sulfate Adult Acute Lymphoblastic Leukemia	University of Washington	P3	BB (68)
Blinatumomab Adult Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P3	BB (67)
Sirolimus Adult Acute Lymphoblastic Leukemia	Roswell Park Cancer Institute	P2	BB (67)
Romidepsin Adult Acute Lymphoblastic Leukemia	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran	P2/3	BB (66)
Melphalan Adult Acute Lymphoblastic Leukemia	Roswell Park Cancer Institute	P2	BB (65)
Nivestim Adult Acute Lymphoblastic Leukemia	Case Comprehensive Cancer Center	P2	BB (65)
Treosulfan Adult Acute Lymphoblastic Leukemia	St. Anna Kinderkrebsforschung	P2/3	BB (65)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Adult Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P2/3	BB (64)
Bortezomib Adult Acute Lymphoblastic Leukemia	Indiana University	P2	BB (64)
Imatinib Adult Acute Lymphoblastic Leukemia	PETHEMA Foundation	P3	BB (64)
Tucidinostat Adult Acute Lymphoblastic Leukemia	Nanfang Hospital, Southern Medical University	P2/3	BB (64)
Daratumumab Adult Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (60)
Dasatinib Adult Acute Lymphoblastic Leukemia	First Affiliated Hospital Xi'an Jiaotong University	P2	B (60)
Ponatinib Adult Acute Lymphoblastic Leukemia	PETHEMA Foundation	P3	B (60)
Clofarabine Adult Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P2	B (59)
Anti-Human T-Lymphocyte Immunoglobulin From Rabbits Adult Acute Lymphoblastic Leukemia	St. Anna Kinderkrebsforschung	P2/3	B (57)
Venetoclax Adult Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2/3	CCC (55)
Anti-Cd19 Car T-Cells Adult Acute Lymphoblastic Leukemia	KK Women's and Children's Hospital	P2	CCC (53)
Ebx-102 Adult Acute Lymphoblastic Leukemia	Imperial College London	P2	CCC (53)
NK-92 Adult Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P2	CCC (53)
Olverembatinib Adult Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (53)
Plerixafor Adult Acute Lymphoblastic Leukemia	The First Hospital of Jilin University	P2	CCC (53)
Autologous Cd19-Directed Chimeric Antigen Receptor T-Cells Adult Acute Lymphoblastic Leukemia	University of Alberta	P1/2	CCC (48)
Tbi-1501 Adult Acute Lymphoblastic Leukemia	Takara Bio Inc.	P1/2	CCC (48)
azd3632 Adult Acute Lymphoblastic Leukemia	AstraZeneca	P1/2	CC (47)
BN104 Adult Acute Lymphoblastic Leukemia	Institut de Recherches Internationales Servier (I.R.I.S.)	P1/2	CC (47)
Posaconazole Adult Acute Lymphoblastic Leukemia	AstraZeneca	P1/2	CC (47)
Inotuzumab Ozogamicin Adult Acute Lymphoblastic Leukemia	Ruijin Hospital	P1	CC (46)
cd19-ucart Adult Acute Lymphoblastic Leukemia	University Hospital Heidelberg	P1/2	CC (45)
Sitagliptin Adult Acute Lymphoblastic Leukemia	Indiana University	P1/2	CC (45)
Tgrx-814 Adult Acute Lymphoblastic Leukemia	Shenzhen TargetRx Co., Ltd.	P1/2	CC (45)

Showing 1 to 50 of 66 assets

PreviousPage 1 of 2Next